TrialChinese medical journal2018

Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study.

Wei Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.